Evaluación de la eficacia y seguridad del diodo láser micropulsado en el tratamiento de glaucoma: un año de seguimiento

MicroPulse Transscleral Laser Therapy in Patients With Glaucoma and Ocular Cicatricial Pemphigoid

“…The exclusion criteria was in accordance with a previously developed research protocol published in 2020 by the same study group. 7 Demographic characteristics and staging of OCP after the Foster classification system 8 were recorded before MP-TLT and at last follow-up. OCP topical and systemic treatment was also described.…”

“…), using the same standardized parameters for the procedure, as previously published. 7 The Cyclo G6 laser system through the Micro-Pulse P3 device was used (MP-TLT; IRIDEX IQ810 Laser Systems, Mountain View, CA), with an infrared wavelength of 810 nm, with a duty cycle of 31.33%, 2000 mW of power. IOP results were recorded, as mean, standard deviation, and range.…”

“…Were included eyes that had uncontrolled IOP refractory to topical anti-glaucomatous treatment, and/or with ocular surface intolerance to these medications. The exclusion criteria was in accordance with a previously developed research protocol published in 2020 by the same study group 7 …”

“…MP-TLT was performed by three experienced glaucoma surgeons (V.Z., C.L., M.F.D. ), using the same standardized parameters for the procedure, as previously published 7 . The Cyclo G6 laser system through the MicroPulse P3 device was used (MP-TLT; IRIDEX IQ810 Laser Systems, Mountain View, CA), with an infrared wavelength of 810 nm, with a duty cycle of 31.33%, 2000 mW of power.…”